MSB 7.69% $1.19 mesoblast limited

MSB to dispute FDA finding in Type A meeting, page-124

  1. 2,476 Posts.
    lightbulb Created with Sketch. 274
    Sorry son. The market proved me right today, and you and everyone else like you, wrong.

    You get to suck it up friend.


    And there is no other MSC treatment out there - that's my point.

    It was an unprecedented decision. To think the FDA were going to just casually meander in this new world of regenerative medicine with any reservations, is absurd.

    All the evidence was there if you cared to see it.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.